These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
798 related items for PubMed ID: 16249495
1. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma. Hains BC, Waxman SG. Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495 [Abstract] [Full Text] [Related]
2. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice. Zhong L, Bradley J, Schubert W, Ahmed E, Adamis AP, Shima DT, Robinson GS, Ng YS. Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1212-8. PubMed ID: 17325165 [Abstract] [Full Text] [Related]
3. Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration. Yoles E, Wheeler LA, Schwartz M. Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):65-73. PubMed ID: 9888428 [Abstract] [Full Text] [Related]
4. Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma. Jiang C, Moore MJ, Zhang X, Klassen H, Langer R, Young M. Mol Vis; 2007 Sep 24; 13():1783-92. PubMed ID: 17960131 [Abstract] [Full Text] [Related]
5. Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats. Levkovitch-Verbin H, Quigley HA, Martin KR, Valenta D, Baumrind LA, Pease ME. Invest Ophthalmol Vis Sci; 2002 Feb 24; 43(2):402-10. PubMed ID: 11818384 [Abstract] [Full Text] [Related]
6. Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma. Crandall J, Matragoon S, Khalifa YM, Borlongan C, Tsai NT, Caldwell RB, Liou GI. Ophthalmic Res; 2007 Feb 24; 39(2):69-75. PubMed ID: 17284931 [Abstract] [Full Text] [Related]
7. Effects of acute delivery of endothelin-1 on retinal ganglion cell loss in the rat. Lau J, Dang M, Hockmann K, Ball AK. Exp Eye Res; 2006 Jan 24; 82(1):132-45. PubMed ID: 16045909 [Abstract] [Full Text] [Related]
8. Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, II: Structural measures. Hare WA, WoldeMussie E, Weinreb RN, Ton H, Ruiz G, Wijono M, Feldmann B, Zangwill L, Wheeler L. Invest Ophthalmol Vis Sci; 2004 Aug 24; 45(8):2640-51. PubMed ID: 15277487 [Abstract] [Full Text] [Related]
9. Neuroprotective effects of Lycium barbarum Lynn on protecting retinal ganglion cells in an ocular hypertension model of glaucoma. Chan HC, Chang RC, Koon-Ching Ip A, Chiu K, Yuen WH, Zee SY, So KF. Exp Neurol; 2007 Jan 24; 203(1):269-73. PubMed ID: 17045262 [Abstract] [Full Text] [Related]
10. Detection of early neuron degeneration and accompanying microglial responses in the retina of a rat model of glaucoma. Naskar R, Wissing M, Thanos S. Invest Ophthalmol Vis Sci; 2002 Sep 24; 43(9):2962-8. PubMed ID: 12202516 [Abstract] [Full Text] [Related]
11. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma. Bosco A, Inman DM, Steele MR, Wu G, Soto I, Marsh-Armstrong N, Hubbard WC, Calkins DJ, Horner PJ, Vetter ML. Invest Ophthalmol Vis Sci; 2008 Apr 24; 49(4):1437-46. PubMed ID: 18385061 [Abstract] [Full Text] [Related]
13. Neuroprotective effect of nipradilol [3,4-dihydro-8-(2-hydroxy-3-isopropylamino)-propoxy-3-nitroxy-2H-1-benzopyran] in a rat model of optic nerve degeneration. Karim MZ, Sawada A, Mizuno K, Kawakami H, Ishida K, Yamamoto T. J Glaucoma; 2009 Jan 24; 18(1):26-31. PubMed ID: 19142131 [Abstract] [Full Text] [Related]
14. Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments. Hernández M, Urcola JH, Vecino E. Exp Eye Res; 2008 May 24; 86(5):798-806. PubMed ID: 18394603 [Abstract] [Full Text] [Related]
15. Retinal damage after 3 to 4 months of elevated intraocular pressure in a rat glaucoma model. Mittag TW, Danias J, Pohorenec G, Yuan HM, Burakgazi E, Chalmers-Redman R, Podos SM, Tatton WG. Invest Ophthalmol Vis Sci; 2000 Oct 24; 41(11):3451-9. PubMed ID: 11006238 [Abstract] [Full Text] [Related]
16. An agonistic TrkB mAb causes sustained TrkB activation, delays RGC death, and protects the retinal structure in optic nerve axotomy and in glaucoma. Bai Y, Xu J, Brahimi F, Zhuo Y, Sarunic MV, Saragovi HU. Invest Ophthalmol Vis Sci; 2010 Sep 24; 51(9):4722-31. PubMed ID: 20357199 [Abstract] [Full Text] [Related]
17. Correlation between retinal ganglion cell death and chronically developing inherited glaucoma in a new rat mutant. Thanos S, Naskar R. Exp Eye Res; 2004 Jul 24; 79(1):119-29. PubMed ID: 15183107 [Abstract] [Full Text] [Related]
18. Topically administered timolol and dorzolamide reduce intraocular pressure and protect retinal ganglion cells in a rat experimental glaucoma model. Seki M, Tanaka T, Matsuda H, Togano T, Hashimoto K, Ueda J, Fukuchi T, Abe H. Br J Ophthalmol; 2005 Apr 24; 89(4):504-7. PubMed ID: 15774933 [Abstract] [Full Text] [Related]
19. Three experimental glaucoma models in rats: comparison of the effects of intraocular pressure elevation on retinal ganglion cell size and death. Urcola JH, Hernández M, Vecino E. Exp Eye Res; 2006 Aug 24; 83(2):429-37. PubMed ID: 16682027 [Abstract] [Full Text] [Related]